Literature DB >> 25716931

Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies.

Pasquale Ambrosino, Roberta Lupoli, Alessandro Di Minno, Marco Tasso, Rosario Peluso, Matteo Nicola Dario Di Minno1.   

Abstract

We performed a systematic review with meta-analysis and meta-regression of literature studies evaluating the impact of rheumatoid arthritis (RA) on common carotid artery intima-media thickness (CCA-IMT) and on the prevalence of carotid plaques. Studies evaluating the relationship between RA and markers of cardiovascular (CV) risk (CCA-IMT and prevalence of carotid plaques) were systematically searched in the PubMed, Web of Science, Scopus and EMBASE databases. A total of 59 studies (4,317 RA patients and 3,606 controls) were included in the final analysis, 51 studies with data on CCA-IMT (52 data-sets on 3,600 RA patients and 3,020 controls) and 35 studies reporting on the prevalence of carotid plaques (2,859 RA patients and 2,303 controls). As compared to controls, RA patients showed a higher CCA-IMT (mean difference [MD]: 0.10 mm; 95 % confidence interval [CI]: 0.07, 0.12; p < 0.00001), and an increased prevalence of carotid plaques (odds ratio [OR]: 3.61; 95 %CI: 2.65, 4.93; p< 0.00001). Interestingly, when analysing studies on early RA, the difference in CCA-IMT among RA patients and controls was even higher (MD: 0.21 mm; 95 %CI: 0.06, 0.35; p=0.006), and difference in the prevalence of carotid plaques was entirely confirmed (OR: 3.57; 95 %CI: 1.69, 7.51; p=0.0008). Meta-regression models showed that male gender and a more severe inflammatory status [as expressed by disease activity score in 28 joints (DAS28), C-reactive protein (CRP) levels, and erythrocyte sedimentation rate (ESR)] significantly impacted on CCA-IMT. In conclusion, RA appears significantly associated with subclinical atherosclerosis and CV risk. These findings can be useful to plan adequate prevention strategies and therapeutic approaches.

Entities:  

Keywords:  Rheumatoid arthritis; cardiovascular risk; carotid plaques; intima-media thickness

Mesh:

Substances:

Year:  2015        PMID: 25716931     DOI: 10.1160/TH14-11-0921

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  27 in total

1.  Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece?

Authors:  Alessandro Mantovani; Cristian Caimmi; Giovanni Orsolini
Journal:  Clin Rheumatol       Date:  2017-10-20       Impact factor: 2.980

Review 2.  Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis.

Authors:  Alexander Kalinkovich; Gulzan Gabdulina; Gregory Livshits
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 3.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 4.  Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.

Authors:  Federico Carbone; Aldo Bonaventura; Luca Liberale; Sabrina Paolino; Francesco Torre; Franco Dallegri; Fabrizio Montecucco; Maurizio Cutolo
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

5.  Patients with rheumatoid arthritis have an increased risk of incident chronic kidney disease: a systematic review and meta-analysis of cohort studies.

Authors:  Sukit Raksasuk; Patompong Ungprasert
Journal:  Int Urol Nephrol       Date:  2019-12-09       Impact factor: 2.370

6.  Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study.

Authors:  Deborah F van Breukelen-van der Stoep; Derkjen van Zeben; Boudewijn Klop; Gert-Jan M van de Geijn; Hans J W Janssen; Mieke J M W Hazes; Erwin Birnie; Noelle van der Meulen; Marijke A De Vries; Manuel Castro Cabezas
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

Review 7.  Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies.

Authors:  Der-Yuan Chen; Tatsuya Sawamura; Richard A F Dixon; José Luis Sánchez-Quesada; Chu-Huang Chen
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

8.  Accelerated atherosclerosis in premenopausal women with rheumatoid arthritis - 15-year follow-up.

Authors:  Metka Koren Krajnc; Radovan Hojs; Iztok Holc; Željko Knez; Artur Pahor
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

9.  The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.

Authors:  Chiara Baldini; Francesca Romana Moriconi; Sara Galimberti; Peter Libby; Raffaele De Caterina
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

10.  Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis.

Authors:  Hyun-Je Kim; Min-Jung Kim; Choong-Ki Lee; Young-Hoon Hong
Journal:  J Korean Med Sci       Date:  2015-10-16       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.